Get the Stockscreener App
4.75
8.70%
0.38
After Hours:
4.75
Forte Biosciences Inc stock is traded at $4.75, with a volume of 17,743.
It is up +8.70% in the last 24 hours and down -5.38% over the past month.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
See More
Previous Close:
$4.37
Open:
$4.47
24h Volume:
17,743
Relative Volume:
1.55
Market Cap:
$6.57M
Revenue:
-
Net Income/Loss:
$-31.48M
P/E Ratio:
-4.0948
EPS:
-1.16
Net Cash Flow:
$-28.71M
1W Performance:
+3.71%
1M Performance:
-5.38%
6M Performance:
-73.39%
1Y Performance:
-60.42%
1-Day Range:
$4.445
$4.8085
1-Week Range:
$4.11
$4.8085
52-Week Range:
$4.11
$21.25
Forte Biosciences Inc Stock (FBRX) Company Profile
Name
Forte Biosciences Inc
Sector
Industry
Phone
(310) 618-6994
Address
3060 PEGASUS PARK DRIVE, DALLAS, CA
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-20-21 | Upgrade | Chardan Capital Markets | Sell → Buy |
| Sep-03-21 | Downgrade | B. Riley Securities | Buy → Neutral |
| Sep-03-21 | Downgrade | Chardan Capital Markets | Buy → Sell |
| Sep-03-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-03-21 | Downgrade | Truist | Buy → Hold |
| May-14-21 | Initiated | B. Riley Securities | Buy |
| Mar-26-21 | Initiated | Citigroup | Buy |
| Aug-28-20 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Aug-25-20 | Initiated | Truist | Buy |
View All
Forte Biosciences Inc Stock (FBRX) Latest News
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World
Traders Buy Large Volume of Call Options on Alaska Air Group (NYSE:ALK) - Defense World
Avadel Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AVDL) - Defense World
Wendy’s Target of Unusually High Options Trading (NASDAQ:WEN) - Defense World
Traders Buy High Volume of Call Options on Guidewire Software (NYSE:GWRE) - Defense World
Patterson-UTI Energy Sees Unusually Large Options Volume (NASDAQ:PTEN) - Defense World
SIGA Technologies Target of Unusually High Options Trading (NASDAQ:SIGA) - Defense World
Stock Traders Buy Large Volume of Call Options on Etsy (NASDAQ:ETSY) - Defense World
Sunnova Energy International Target of Unusually High Options Trading (NYSE:NOVA) - Defense World
FBRX stock touches 52-week low at $4.41 amid market challenges - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.39% - MSN
Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days - Mugglehead
CSG Forte Engage Honored for Innovation in Top Industry Awards - Yahoo Finance
Organic Propolis Market Report Analysis, Research Studies |Forté Pharma, Propolia, HoneyGreen, Parchem, Bee Health, Vond – IndiaPolitics.com - IndiaPolitics.com
FBRX stock touches 52-week low at $4.8 amid market challenges - Investing.com Australia
FBRX stock touches 52-week low at $4.8 amid market challenges By Investing.com - Investing.com South Africa
(FBRX) Investment Analysis and Advice - Stock Traders Daily
"Forte Opening Solutions" Brand Replaces "Masonite Architectural" While Renewing Commitment to Commercial Customers - Yahoo Finance
FBRX stock touches 52-week low at $4.81 amid market challenges - Investing.com India
United States shares lower at close of trade; Dow Jones Industrial Average down 0.39% - MSN
Stock Traders Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Forte Biosciences Target of Unusually Large Options Trading (NASDAQ:FBRX) - Defense World
When the Price of (FBRX) Talks, People Listen - Stock Traders Daily
FBRX stock touches 52-week low at $6.47 amid market challenges - Investing.com
Forte Biosciences reshuffles board, settles lawsuit - Investing.com India
Forte Biosciences reshuffles board, settles lawsuit By Investing.com - Investing.com Australia
Forte Biosciences Welcomes New Directors Amidst Strategic Changes - TipRanks
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.39% - MSN
Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World
(FBRX) Long Term Investment Analysis - Stock Traders Daily
FBRX stock touches 52-week low at $6.9 amid market challenges - Investing.com
Mind Medicine (MindMed) (OTCMKTS:MMEDF) Trading 5.9% Higher - Defense World
FORTE BIOSCIENCES INC. Trade Ideas — MUN:37T - TradingView
Forte Biosciences executes reverse stock split - Investing.com
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Significant Growth in Short Interest - MarketBeat
FBRX stock touches 52-week high at $8.62 amid market fluctuations - Investing.com Canada
Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested - Yahoo Finance
Upcoming Stock Splits This Week (August 26 to August 30) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News
Forte Biosciences announces stockholder-approved equity plan By Investing.com - Investing.com Australia
Forte Biosciences announces stockholder-approved equity plan - Investing.com
Forte Biosciences: Key Outcomes from 2024 Stockholders Meeting - TipRanks
Verona Pharma plc (VRP.L) (LON:VRP) Stock Price Crosses Above Two Hundred Day Moving Average of $55.00 - Defense World
FY2024 EPS Estimates for Forte Biosciences, Inc. Decreased by Analyst (NASDAQ:FBRX) - Defense World
Autoliv, Inc. (NYSE:ALV) Shares Purchased by SG Americas Securities LLC - Defense World
Lexicon Pharmaceuticals’ (LXRX) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Augean (LON:AUG) Shares Cross Below 200 Day Moving Average of $371.00 - Defense World
Nisa Investment Advisors LLC Has $1.81 Million Stock Position in Whirlpool Co. (NYSE:WHR) - Defense World
First Savings Financial Group (NASDAQ:FSFG) Stock Price Passes Above Two Hundred Day Moving Average of $17.50 - Defense World
Forte Biosciences Inc Stock (FBRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Forte Biosciences Inc Stock (FBRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wagner Paul A. | SEE REMARKS |
Oct 01 '24 |
Option Exercise |
0.00 |
1,250 |
0 |
77,568 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jul 01 '24 |
Option Exercise |
0.00 |
9,375 |
0 |
203,849 |
| Wagner Paul A. | SEE REMARKS |
Jul 01 '24 |
Option Exercise |
0.00 |
31,250 |
0 |
1,910,424 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Apr 01 '24 |
Option Exercise |
0.00 |
9,375 |
0 |
197,819 |
| Wagner Paul A. | SEE REMARKS |
Apr 01 '24 |
Option Exercise |
0.00 |
31,250 |
0 |
1,881,627 |
| Chen Hubert C | See remarks |
Jan 01 '24 |
Option Exercise |
0.00 |
7,500 |
0 |
96,478 |
| Riley Antony A | Chief Financial Officer |
Jan 01 '24 |
Option Exercise |
0.00 |
9,375 |
0 |
192,285 |
| Wagner Paul A. | See Remarks |
Jan 01 '24 |
Option Exercise |
0.00 |
31,250 |
0 |
1,854,486 |
| Wagner Paul A. | See Remarks |
Dec 18 '23 |
Buy |
0.75 |
10,000 |
7,525 |
1,823,236 |
| Wagner Paul A. | See Remarks |
Dec 13 '23 |
Buy |
0.70 |
10,520 |
7,351 |
1,803,236 |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):